Vestis Corp

VSTS remains in a Stage 2 advancing regime with clear higher highs and higher lows and rising EMAs. Price is currently extended with extreme overbought readings on RSI and Options Score, suggesting near-term exhaustion. Medium-term bullish bias stays intact, but execution should await a shallow pullback into the rising 9/21 EMA confluence near prior breakout support. Key risks include a sharp reversal from exhaustion or breach of the EMA cluster that would invalidate the structure.

• ↑Q2 adjusted EBITDA $75 M, up 19% YoY; full-year guidance lifted to $295–325 M.
• ↑Q2 free cash flow $74 M; targeting $120–150 M by FY2026 on efficiency gains.
• ↓Q2 revenue $659 M, down 0.9% YoY, marking three years of flat growth.